3. D. Z. Kochan et al., “Circadian Disruption and Breast Cancer: An Epigenetic Link?” Oncotarget, 6, no. 19 (2015): 16866-16682. DOI:10.18632/oncotarget.4343.
4. M. Dunbar and R. Melton, “The Lowdown on Light: Good vs. Bad, and Its Connection to AMD,” Review of Optometry, https://www.reviewofoptometry.com/ce/ the-lowdown-on-blue-light-good-vs-bad-and-its-connection-toamd-109744, accessed November 28, 2016.
5. D. Peretti et al., “RBM3 Mediates Structural Plasticity and Protective Effects of Cooling in Neurodegeneration” Nature, 518, no. 7538 (2015): 236–239, DOI: 10.1038/nature 14142.
Приложение А
1. Load Diet in Treatment of Acne Vulgaris in Korean Patients: A Randomized, Controlled Trial.” Acta Dermato Venereologica, 92, no. 3 (May 2012): 241–246, DOI: 10.2340/00015555-1346.
2. L. Knott et al., “Regulation of Osteoarthritis by Omega-3 (n-3) Polyunsaturated Fatty Acids in a Naturally Occurring Model of Disease,” Osteoarthritis Cartilage, 19, no. 9 (September 2011): 1150–1157, DOI: 10.1016/j.joca.2011.06.005.
3. L. Cordain et al., “Acne Vulgaris: A Disease of Western Civilization,” Archives of Dermatology, 138, no. 12 (December 2002): 1584–1590, DOI: 10.1001/arch-derm.138.12.1584.
4. R. N. Smith et al., “A Low-Glycemic-Load Diet Improves Symptoms in Acne Vulgaris Patients: A Randomized Controlled Trial,” American Journal of Clinical Nutrition, 86, no. 1 (July 2007): 107–115.
5. Kwon et al., “Clinical and Histological Effect of a Low Glycaemic Load Diet in Treatment of Acne Vulgaris in Korean Patients.”
6. S. N. Mahmood and W.P. Bowe, “Diet and Acne Update: Carbohydrates Emerge as the Main Culprit,” Journal of Drugs in Dermatology, 13, no. 4 (April 2014): 428–435.
7. “2015 Alzheimer’s Disease Facts and Figures,” Alzheimer’s Association, https://www. alz.org/facts/downloads/facts_figures_2015.pdf, accessed November 28, 2016.
8. World Health Organization. “Dementia: a Public Health Priority” (Geneva, SUI: World Health Organization, 2012), PMID: 19712582.
9. B. D. James et al., “Contribution of Alzheimer Disease to Mortality in the United States,” Neurology,published online before print March 5, 2014, DOI: 10.1212/ WNL.0000000000000240.
10. V. R. Bitra, D. Rapaka, and A. Akula, “Prediabetes and Alzheimer’s Disease,” Indian Journal of Pharmaceutical Sciences, 77, no. 5 (2015): 511–514.
11. S. M. de la Monte, “Insulin Resistance and Alzheimer’s Disease,” BMB Reports, 42, no. 8 (2009): 475–481.
12. R. O. Roberts et al., “Relative Intake of Macronutrients Impacts Risk of Mild Cognitive Impairment or Dementia,” Journal of Alzheimer s Disease, 32, no. 2 (2012), 329–339. DOI: 10.3233/JAD-2012-120862.
13. S. T. Henderson et al., “Study of the Ketogenic Agent AC-1202 in Mild to Moderate Alzheimer’s Disease: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial,” Nutrition & Metabolism, 6 (2009): 31. DOI: 10.1186/1743-7075-6-31, PMID: 19664276.
14. }. Yao and R. D. Brinton, “Targeting Mitochondrial Bioenergetics for Alzheimer’s Prevention and Treatment,” Current Pharmaceutical Design, 17, no. 31 (2011): 3474–3479, PMID: 21902662.
15. J. M. Hootman et al., “Updated Projected Prevalence of Self-Reported Doctor-Diagnosed Arthritis and Arthritis-Attributable Activity Limitation Among US Adults, 2015–2040.” Arthritis & Rheumatololgy, 68, no. 7 (July 2016): 1582–1587, DOI: 10.1002/art.39692.
16. Knott et al., “Regulation of Osteoarthritis by Omega-3 (n-3) Polyunsaturated Fatty Acids in a Naturally Occurring Model of Disease.”
17. Y. M. Bastiaansen-Jenniskens et al., “Monounsaturated and Saturated, but Not n-6 Polyunsaturated Fatty Acids Decrease Cartilage Destruction under Inflammatory Conditions: A Preliminary Study.” Cartilage, 4 no. 4 (2013), 321–328. DOI: 10.1177/1947603513494401.
18. D. N. Ruskin, M. Kawamura, and S. A. Masino, “Reduced Pain and Inflammation in Juvenile and Adult Rats Fed a Ketogenic Diet,” PLoS One, 4, no. 12 (2009): e8349, D01:10.1371/journal.pone.0008349.
19. S. A. Masino and D. N. Ruskin, “Ketogenic Diets and Pain,” Journal of Child Neurology, 28, no. 8 (2013): 993-1001. DOI: 10.1177/0883073813487595.
20. “Vital Signs: Preventable Deaths from Heart Disease & Stroke,” Centers for Disease Control and Prevention, http://www.cdc.gov/dhdsp/vital_signs.htm, accessed November 28, 2016.
21. B. Hoogwerf et al., “Blood Glucose Concentrations <125 mg/dl and Coronary Heart Disease Risk J American Journal of Cardiology, 89, no. 5, (2002): 596–599, DOI: 10.1016/S0002-9149(01)02302-5.
22. N. V Dhurandhar and D. Thomas, “The Link between Dietary Sugar Intake and Cardiovascular Disease Mortality: An Unresolved Question,” Journal of the American Medical Association, 313, no. 9 (2015): 959–960. DOI: 10.1001/jama.2014.18267, accessed 12/2/16.
23. Q. Yang et al., “Added Sugar Intake and Cardiovascular Diseases Mortality Among US Adults,” JAMA Internal Medicine, 174, no. 4 (2014), 516–524, DOI: 10.1001/ jamainternmed.2013.13563.
24. L. Schwingshackl et al., “Comparison of Effects of Long-Term Low-Fat vs High-Fat Diets on Blood Lipid Levels in Overweight or Obese Patients: A Systematic Review and Meta-Analysis.” Journal of the Academy of Nutrition and Dietetics, 113, no. 12 (2013), 1640–1661, DOI: 10.1016/j.jand.2013.07.010.
25. C. L. Gibson, A. N. Murphy, and S. P. Murphy, “Stroke Outcome in the Ketogenic State: A Systematic Review of the Animal Data,” Journal of Neurochemistry, 123, no. 2 (2012), 52–57, DOI: 10.1111/j.l471-4159.2012.07943.x.
26. “Epilepsy Fast Facts,” Centers for Disease Control and Prevention, http://www.cdc. gov/epilepsy/basics/fast-facts.htm, accessed November 28, 2016.
27. J. W. Wheless, “History of the Ketogenic Diet,” Epilepsia, 49, Suppl. 8 (November 2008): 3–5, DOI: 10.111 l/j.1528–1167.2008.01821.x.
28. K. Martin et al, “Ketogenic Diet and Other Dietary Treatments for Epilepsy,” Cochrane Database of Systematic Reviews, 2 (2016), DOI: 10.1002/14651858. CD001903.pub3.
29. “What Is Fibromyalgia?” (November 2014), http://www.niams.nih.gov/.
30. Mayo Clinic, “Diseases and Conditions: Fibromyalgia,” http://www.mayoclinic. org/diseases-conditions/fibromyalgia/basics/causes/con-20019243, accessed November 28, 2016.
31. Paper presented at the Annual Meeting of the American College of Nutrition in Orlando, Florida, October 2001.
32. M. Meeus et al., “The Role of Mitochondrial Dysfunctions Due to Oxidative and Nitrosative Stress in the Chronic Pain or Chronic Fatigue Syndromes and Fibromyalgia Patients: Peripheral and Central Mechanisms as Therapeutic Targets?” Expert Opinion on Therapeutic Target, 17, no. 9 (2013): 1081–1089, DOI: 10.1517/14728222.2013.818657.
